Skip Navigation

Published Manuscripts

The Bronchiectasis and NTM Research Registry is a clinician-reported, longitudinal database of detailed medical information from thousands of people with non-CF bronchiectasis and/or NTM lung disease.

The following published manuscripts present research derived from the Bronchiectasis and NTM Research Registry.

The following published manuscripts present research derived from the Bronchiectasis and NTM Research Registry.

Results

Marmor M, Brunton AE, Fraulino D, et.al. The Association Between Incident Nontuberculous Mycobacteria Isolation and Antibiotic Exposure in Patients with Bronchiectasis. CHEST.

2025

Aksamit A, Choate R, Mannino D, et.al. Natural history and burden of refractory Mycobacterium avium complex pulmonary disease: insights from the US Bronchiectasis and Nontuberculous Mycobacterial Research Registry. Resp Med.

2025

Aksamit T, Lapinel L, Choate R. Association between bronchiectasis exacerbations and longitudinal changes in FEV1 in patients from the US bronchiectasis and NTM research registry. Respir Med.

2024

McShane PJ, Brunton, AE, Choate, R, et.al. Impact of Tobacco Smoking in Bronchiectasis: Data from the U.S. Bronchiectasis and Nontuberculous Mycobacteria Research Registry. Am J Respir Crit Care Med.

2024

Lapinel NC, Choate, C, Aksamit A, et. al. Characteristics of exacerbators in the US Bronchiectasis and NTM Research Registry: a cross-sectional study. ERJ Open Res.

2024

Aksamit TR, Locantore N, Addrizzo-Harris D, et al. Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients. Am J Respir Crit Care Med.

2024

Basavaraj A, Brunton AE, Choate R, et.al. Nebulized hypertonic saline and positive expiratory pressure device use in patients with bronchiectasis: Analysis from the United States Bronchiectasis and NTM Research Registry. Respir Res.

2024

Basavaraj A, Choate R, Becker C, et.al. Severity of Bronchiectasis Predicts use of and Adherence to High Frequency Chest Wall Oscillation Therapy - Analysis from the United States Bronchiectasis and NTM Research Registry. Respir Med.

2024

Karamooz E, Brixey A, Rydzak C et.al. Prevalence of Pulmonary Artery Dilation in Non-Cystic Fibrosis Bronchiectasis: A CT Analysis from a Cohort of the US Bronchiectasis and Nontuberculous Mycobacteria Research Registry. J Thorac Dis.

2024

Drysdale M, Choate R, Brunton AE, et al. Nontuberculous Mycobacterial (NTM) Infections in Bronchiectasis Patients: A Retrospective US Registry Cohort Study. Pulm Pharmacol Ther.

2023

Drysdale M, Choate R, Brunton AE, et al. Racial and Ethnic Differences in Patients Enrolled in the National Bronchiectasis and Nontuberculous Mycobacteria Research Registry. Respir Med.

2023

Ku JH, Henkle E, Aksamit TR, et al. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clin Infect Dis.

2023

Henkle E, Brunton AE, Aksamit TR, Winthrop KL. Isolation of Pseudomonas aeruginosa after nontuberculous mycobacteria. IJTLD

2022

Metersky ML, Choate R, Aksamit TR, et.al. Stenotrophomonas maltophilia in patients with bronchiectasis: An analysis of the US bronchiectasis and NTM Research Registry. Respir Med.

2022

McShane PJ, Philley JV, Prieto DA, et. al. Global attitudes of health care providers about aerosolized airway clearance therapy in bronchiectasis patients during the coronavirus disease 2019 pandemic. Chronic Obstr Pulm Dis.

2021

Metersky ML, Choate R. The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients with Bronchiectasis. Chest.

2021

Pravosud V, Mannino DM, Prieto D, et al. Symptom burden and medication use among patients with nontuberculous mycobacterial lung disease. Chronic Obstr Pulm Dis.

2021

Choate R, Aksamit TR, Manino D, et el. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR). Resp Med.

2021

Basavaraj A, Choate R, Addrizzo-Harris D, et al. Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry. Chest

2020

Despotes KA, Choate R, Addrizzo-Harris D, et al. Nutrition and Markers of Disease Severity in Patients with Bronchiectasis. Chest

2020

Eden E, Choate R, Barker A, et al. The clinical features of bronchiectasis associated with alpha-1 antitrypsin deficiency, common variable immunodeficiency and primary ciliary dyskinesia--results from the U.S. Bronchiectasis Research Registry. Chronic Obstr Pulm Dis.

2019

Henkle E, Aksamit TR, Daley CL, et al. US Patient-Centered Research Priorities and Roadmap for Bronchiectasis. Chronic Obstr Pulm Dis.

2018

Metersky ML, Aksamit TR, Barker A, et al. The prevalence and significance of Staphylococcus aureus in patients with non–cystic fibrosis bronchiectasis. Ann Am Thorac Soc.

2018

Henkle E, Chan B, Curtis JR, et al. Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees with Prescription Drug Plans, 2006 to 2014. Chest

2018

Henkle E, Curtis JR, Chen L, et al. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Chest

2018

Henkle E, Aksamit TR, Barker AF, et al. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest

2017

Ruffner MA, Aksamit TR, Thomashow B, et al. Frequency of untreated hypogammaglobulinemia in bronchiectasis. Ann Allergy Asthma Immunol.

2017

Aksamit TR, O’Donnell AE, Barker, A, et al. Adult Patients with Bronchiectasis a First Look at the US Bronchiectasis Research Registry. Ann Allergy Asthma Immunol.

2017

This page was reviewed on April 17, 2026 by the Bronchiectasis and NTM Association Content Review and Evaluation Committee.